Great West Life Assurance CO Crinetics Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 17,339 shares of CRNX stock, worth $932,144. This represents 0.0% of its overall portfolio holdings.
Number of Shares
17,339
Previous 4,742
265.65%
Holding current value
$932,144
Previous $222,000
249.55%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding CRNX
# of Institutions
244Shares Held
78.2MCall Options Held
268KPut Options Held
197K-
Black Rock Inc. New York, NY6.23MShares$335 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.11MShares$329 Million2.95% of portfolio
-
Wellington Management Group LLP Boston, MA4.62MShares$248 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.51MShares$243 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.41MShares$237 Million0.02% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $2.89B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...